Research Areas

As a research-focused company with over 100 scientific publications, Biosfer Teslab is dedicated to advancing scientific knowledge in various application fields. Our core mission involves conducting rigorous scientific investigations, experimental designs, and data analysis to contribute valuable insights to the global scientific community. To disseminate our findings effectively, Biosfer Teslab consistently publishes peer-reviewed scientific articles, showcasing the power of our technology, fostering collaboration, and facilitating the exchange of ideas and solutions in pursuit of a deeper understanding of metabolism in multiple application fields. 

Abstract Background and aims: Comprehensive assessment of pharmacotherapy effects on atherogenic parameters (AP) that influence …

Abstract Fecal biomarkers are becoming an important analytical tool since feces are in direct contact …

Abstract Introduction Empagliflozin and sacubitril/valsartan reduce cardiovascular mortality and heart failure hospitalization rates, but the …

Abstract There is growing evidence linking growth differentiation factor 15 (GDF15) to both metabolic dysfunction-associated …

Abstract Background/Objectives: Assessing nutrient intake is essential for understanding body homeostasis and diet-health interactions. Traditional …

Abstract Background: Empagliflozin and sacubitril/valsartan are established in heart failure treatment, but their effects after …

Abstract Cardiovascular diseases keep being the leading cause of mortality in Spain. Efforts should be …

Abstract Background and aims: We aimed to assess the associations of exposure to air pollutants …

Abstract Background and aim: Triglycerides (TG) are independent cardiovascular risk markers, yet TG-lowering therapies have …